Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,715 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical evaluation of palliative chemoradiotherapy for metastatic esophageal cancer.
Ueda H, Takeda M, Ueda S, Kawakami H, Okuno T, Takegawa N, Hayashi H, Tsurutani J, Tamura T, Ishikawa K, Nishimura Y, Nakagawa K. Ueda H, et al. Among authors: nakagawa k. Oncotarget. 2017 May 17;8(46):80286-80294. doi: 10.18632/oncotarget.17925. eCollection 2017 Oct 6. Oncotarget. 2017. PMID: 29113302 Free PMC article.
Mutational analysis of the beta-tubulin gene in lung cancer.
Tsurutani J, Komiya T, Uejima H, Tada H, Syunichi N, Oka M, Kohno S, Fukuoka M, Nakagawa K. Tsurutani J, et al. Among authors: nakagawa k. Lung Cancer. 2002 Jan;35(1):11-6. doi: 10.1016/s0169-5002(01)00291-4. Lung Cancer. 2002. PMID: 11750707
Phase I/II trial of sequential chemoradiotherapy using a novel hypoxic cell radiosensitizer, doranidazole (PR-350), in patients with locally advanced non-small-cell lung Cancer (WJTOG-0002).
Nishimura Y, Nakagawa K, Takeda K, Tanaka M, Segawa Y, Tsujino K, Negoro S, Fuwa N, Hida T, Kawahara M, Katakami N, Hirokawa K, Yamamoto N, Fukuoka M, Ariyoshi Y. Nishimura Y, et al. Among authors: nakagawa k. Int J Radiat Oncol Biol Phys. 2007 Nov 1;69(3):786-92. doi: 10.1016/j.ijrobp.2007.04.008. Epub 2007 May 23. Int J Radiat Oncol Biol Phys. 2007. PMID: 17512126 Clinical Trial.
Phase I study of YM155, a novel survivin suppressant, in patients with advanced solid tumors.
Satoh T, Okamoto I, Miyazaki M, Morinaga R, Tsuya A, Hasegawa Y, Terashima M, Ueda S, Fukuoka M, Ariyoshi Y, Saito T, Masuda N, Watanabe H, Taguchi T, Kakihara T, Aoyama Y, Hashimoto Y, Nakagawa K. Satoh T, et al. Among authors: nakagawa k. Clin Cancer Res. 2009 Jun 1;15(11):3872-80. doi: 10.1158/1078-0432.CCR-08-1946. Epub 2009 May 26. Clin Cancer Res. 2009. PMID: 19470738 Clinical Trial.
Phase I clinical and pharmacokinetic study of sorafenib in combination with carboplatin and paclitaxel in patients with advanced non-small cell lung cancer.
Okamoto I, Miyazaki M, Morinaga R, Kaneda H, Ueda S, Hasegawa Y, Satoh T, Kawada A, Fukuoka M, Fukino K, Tanigawa T, Nakagawa K. Okamoto I, et al. Among authors: nakagawa k. Invest New Drugs. 2010 Dec;28(6):844-53. doi: 10.1007/s10637-009-9321-x. Epub 2009 Sep 18. Invest New Drugs. 2010. PMID: 19760364 Free PMC article. Clinical Trial.
4,715 results